Sai Parenteral's Board of Directors

Get the latest insights into the leadership at Sai Parenteral's. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Anil Kumar KarusalaChairman & Managing Director
Vijitha GorrepatiWhole Time Director
Karusala ArunaNon Executive Director
Seeta Ram Anjaneyulu GorantlaNon Executive Independent Director
Bhagyashri Dharmasa ZadNon Executive Independent Director
Kalidindi V RajuNon Executive Independent Director
Shivali AggarwalCompany Secretary & Compliance Officer

Sai Parenteral's Share price

SAIPARENT

485

3.25 (0.67%)
NSE
BSE
Last updated on 22 Apr, 2026 | 12:27 IST
Today's High

487.75

Today's Low

457.70

52 Week Low

400.00

52 Week High

526.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sai Parenteral's FAQs

The board at Sai Parenteral's consists of experienced professionals, including Anil Kumar Karusala, Vijitha Gorrepati, and others, overseeing the company’s strategic and corporate governance.

Directors at Sai Parenteral's are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Anil Kumar Karusala is the current chairman at Sai Parenteral's.

Executive directors at Sai Parenteral's are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Sai Parenteral's adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Sai Parenteral's, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost